It has been shown that increased miR-153 expression results in the loss of PTEN expression in PCa, suggesting that miR-153 can directly target/inhibit PTEN in prostate tumors and promote proliferative lesions [155]. This evidence concerns the gene PTEN and prostate neoplasm.